Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION (OTHER 199175) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 26, 2026 , from http://ppman.hank.ai/transparency/procedure/199175/by-state?code_type=OTHER
“OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION (OTHER 199175) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/199175/by-state?code_type=OTHER. Accessed
June 26, 2026 .
“OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION (OTHER 199175) by State,” HANK Price Transparency ,
accessed June 26, 2026 ,
http://ppman.hank.ai/transparency/procedure/199175/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
199175 — Ocrelizumab 30 Mg/ml Intravenous Solution
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$45,427
National median
$39,485 – $68,653
IQR (p25 – p75)
21
hospitals filing
4
states
Walking in without insurance?
Cash / self-pay price
Cash median
$40,559
vs. negotiated
-10.7%
Hospitals reporting
13
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 199175 (OTHER), with interquartile range
State Median p25 p75
MT $94,002 $82,658 $98,226
CO $75,418 $67,635 $100,766
ID $47,336 $42,353 $47,336
UT $42,165 $38,396 $45,953